Thrivent Financial for Lutherans lifted its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 1,557.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 927,309 shares of the real estate investment trust's stock after buying an additional 871,375 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.39% of Sabra Health Care REIT worth $17,258,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in SBRA. Vanguard Group Inc. lifted its holdings in Sabra Health Care REIT by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust's stock worth $516,545,000 after buying an additional 838,654 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Sabra Health Care REIT by 0.8% in the third quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust's stock worth $401,479,000 after purchasing an additional 167,069 shares during the period. Janus Henderson Group PLC boosted its holdings in Sabra Health Care REIT by 2.9% in the first quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust's stock worth $76,701,000 after purchasing an additional 145,548 shares during the period. LSV Asset Management grew its position in shares of Sabra Health Care REIT by 2.5% during the 2nd quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust's stock valued at $67,465,000 after buying an additional 104,800 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Sabra Health Care REIT by 3.8% during the second quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust's stock valued at $52,275,000 after purchasing an additional 124,825 shares during the last quarter. Institutional investors own 99.40% of the company's stock.
Sabra Health Care REIT Price Performance
Sabra Health Care REIT stock traded down $0.04 during midday trading on Thursday, hitting $18.35. The company's stock had a trading volume of 36,136 shares, compared to its average volume of 2,039,144. Sabra Health Care REIT, Inc. has a 12 month low of $12.83 and a 12 month high of $20.03. The company has a market capitalization of $4.34 billion, a PE ratio of 44.85, a price-to-earnings-growth ratio of 2.33 and a beta of 1.25. The stock's 50-day moving average price is $18.64 and its 200-day moving average price is $16.64. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter last year, the company posted $0.34 EPS. Analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.54%. Sabra Health Care REIT's dividend payout ratio is currently 292.69%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on SBRA shares. Truist Financial lifted their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Scotiabank upped their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a report on Friday, October 11th. Citigroup raised shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and raised their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Finally, Wells Fargo & Company raised shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $18.71.
View Our Latest Research Report on Sabra Health Care REIT
About Sabra Health Care REIT
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Further Reading
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.